Nobel Prize for Medicine 2023 - Inserm Newsroom
palma rocchi on X: "Lunar new year in prostate group https://t.co/M2B0pjjMCB" / X
Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity | Oncogene
Loop | Palma Rocchi
Ubu — Robert Wilson
Gli occhi tuoi mi stancano | Naddei | Sabrina Rocchi
palma rocchi (@palmarocchi1) / X
Art Loft I Rocchi, Valderice – Updated 2023 Prices
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer
Palma Rocchi - Group leader - Inserm | LinkedIn
Séminaire Biotechnologies 2023, 6ème édition | Besançon
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer: Molecular Therapy
Nanoparticules et ciblage thérapeutique | CRCM
Christian Rocchi
Nanomolecules and cell targeting | CRCM
L'info passée au crible : Intervention de Palma Rocchi (CRCM) - Inserm pro
Messenger RNA, the key to personalised medicine
Palma ROCCHI | Professor | French Institute of Health and Medical Research | Inserm | Research Center in Oncology of Marseille | Research profile
PSMA-Targeted Radionuclide Therapy and salivary gland toxicity: why does it matter? | Journal of Nuclear Medicine
Coronavirus : « L'utilisation de l'ARN messager est une révolution, pour la vaccination comme pour les thérapies », assure la chercheuse Palma Rocchi
Pharmaceutics | Free Full-Text | Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer
Palma Rocchi - Group leader - Inserm | LinkedIn
Palma Rocchi • Les Expertes - Francophonie
Loop | Palma Rocchi
palma rocchi (@palmarocchi1) / X
Integrative proteomic and phosphoproteomic profiling of prostate cell lines,PLOS ONE - X-MOL
